How no news becomes news. MacCamant likes Xoma, among many other stocks. His views are carried in a Chicago Tribune article. A mention of this same article ends up on the CBS news site. Who know where else this non event will appear. Someday I hope real news gets an even wider distribution.
Biotech stocks worth a look?
CHICAGO -- More breakthrough products, a speedier Food and Drug Administration
approval process, dramatic recent stock price gains and a trend toward consolidation. These
factors are improving the image of the biotechnology stock, long considered a pariah by a
stock market that tends in uncertain times to value dependability and solid earnings over
hopes, dreams and red ink. Stock pickers have mentioned such companies as Agouron
(AGPH), Chiron (CHIR), Isis (ISIP), Imclone Systems (IMCL), AxyS (AXPH), Xoma
(XOMA), Amgen (AMGN), Biogen (BGEN) and others as worth some exploration. (Chicago
Tribune) |
